APPLICATION
ANDA077950
TYPE
ANDA
ORIGINAL APPROVAL
2018-03-14
LATEST ACTION
2024-03-28
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ABACAVIR SULFATEPrescription
ABACAVIR SULFATE EQ 20MG BASE/ML · SOLUTION · ORAL
Approval history
2024-03-28Labeling · Supplement 11 · standardAP
2019-08-16Labeling · Supplement 9 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.